{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:44:29Z","timestamp":1792856669600,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s12035-024-04557-y","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T08:02:51Z","timestamp":1729497771000},"page":"4274-4291","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Dietary Flavonoid Chrysin Functions as a Dual Modulator to Attenuate Amyloid-\u03b2 and Tau Pathology in the Models of Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"62","author":[{"given":"Zhen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shichao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"key":"4557_CR1","doi-asserted-by":"publisher","unstructured":"2021 Alzheimer's disease facts and figures (2021). Alzheimer\u2019s & dementia : the Journal of the Alzheimer\u2019s Association 17 (3):327\u2013406. https:\/\/doi.org\/10.1002\/alz.12328","DOI":"10.1002\/alz.12328"},{"issue":"1","key":"4557_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW (2019) The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener 14(1):32. https:\/\/doi.org\/10.1186\/s13024-019-0333-5","journal-title":"Mol Neurodegener"},{"issue":"5440","key":"4557_CR3","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.286.5440.735","volume":"286","author":"R Vassar","year":"1999","unstructured":"Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S et al (1999) Beta-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286(5440):735\u2013741. https:\/\/doi.org\/10.1126\/science.286.5440.735","journal-title":"Science"},{"key":"4557_CR4","doi-asserted-by":"publisher","first-page":"102033","DOI":"10.1016\/j.arr.2023.102033","volume":"90","author":"MG Fronza","year":"2023","unstructured":"Fronza MG, Alves D, Pratic\u00f2 D, Savegnago L (2023) The neurobiology and therapeutic potential of multi-targeting \u03b2-secretase, glycogen synthase kinase 3\u03b2 and acetylcholinesterase in Alzheimer\u2019s disease. Ageing Res Rev 90:102033. https:\/\/doi.org\/10.1016\/j.arr.2023.102033","journal-title":"Ageing Res Rev"},{"issue":"1","key":"4557_CR5","doi-asserted-by":"publisher","first-page":"e12050","DOI":"10.1002\/trc2.12050","volume":"6","author":"J Cummings","year":"2020","unstructured":"Cummings J, Lee G, Ritter A, Sabbagh M, Zhong K (2020) Alzheimer\u2019s disease drug development pipeline: 2020. Alzheimers Dement (N Y) 6(1):e12050. https:\/\/doi.org\/10.1002\/trc2.12050","journal-title":"Alzheimers Dement (N Y)"},{"issue":"4","key":"4557_CR6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1312889","volume":"370","author":"RS Doody","year":"2014","unstructured":"Doody RS, Thomas RG, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, Raman R, Alzheimer\u2019s Disease Cooperative Study Steering C, Solanezumab Study G et al (2014) Phase 3 trials of solanezumab for mild-to-moderate Alzheimer\u2019s disease. N Engl J Med 370(4):311\u2013321. https:\/\/doi.org\/10.1056\/NEJMoa1312889","journal-title":"N Engl J Med"},{"issue":"12","key":"4557_CR7","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41582-023-00883-2","volume":"19","author":"EE Congdon","year":"2023","unstructured":"Congdon EE, Ji C, Tetlow AM, Jiang Y, Sigurdsson EM (2023) Tau-targeting therapies for Alzheimer disease: current status and future directions. Nat Rev Neurol 19(12):715\u2013736. https:\/\/doi.org\/10.1038\/s41582-023-00883-2","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"4557_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00401-020-02196-w","volume":"140","author":"SA Kent","year":"2020","unstructured":"Kent SA, Spires-Jones TL, Durrant CS (2020) The physiological roles of tau and A\u03b2: implications for Alzheimer\u2019s disease pathology and therapeutics. Acta Neuropathol 140(4):417\u2013447. https:\/\/doi.org\/10.1007\/s00401-020-02196-w","journal-title":"Acta Neuropathol"},{"issue":"1","key":"4557_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41531-021-00213-7","volume":"7","author":"H Wang","year":"2021","unstructured":"Wang H, Yang F, Zhang S, Xin R, Sun Y (2021) Genetic and environmental factors in Alzheimer\u2019s and Parkinson\u2019s diseases and promising therapeutic intervention via fecal microbiota transplantation. NPJ Parkinsons Dis 7(1):70. https:\/\/doi.org\/10.1038\/s41531-021-00213-7","journal-title":"NPJ Parkinsons Dis"},{"issue":"22","key":"4557_CR10","doi-asserted-by":"publisher","first-page":"e2259","DOI":"10.1212\/WNL.0000000000207176","volume":"100","author":"P Agarwal","year":"2023","unstructured":"Agarwal P, Leurgans SE, Agrawal S, Aggarwal NT, Cherian LJ, James BD, Dhana K, Barnes LL et al (2023) Association of Mediterranean-DASH intervention for neurodegenerative delay and Mediterranean diets with Alzheimer disease pathology. Neurology 100(22):e2259\u2013e2268. https:\/\/doi.org\/10.1212\/WNL.0000000000207176","journal-title":"Neurology"},{"issue":"3","key":"4557_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/alz.12421","volume":"18","author":"S Hoscheidt","year":"2022","unstructured":"Hoscheidt S, Sanderlin AH, Baker LD, Jung Y, Lockhart S, Kellar D, Whitlow CT, Hanson AJ et al (2022) Mediterranean and Western diet effects on Alzheimer\u2019s disease biomarkers, cerebral perfusion, and cognition in mid-life: a randomized trial. Alzheimer Dement J Alzheimer\u2019s Assoc 18(3):457\u2013468. https:\/\/doi.org\/10.1002\/alz.12421","journal-title":"Alzheimer Dement J Alzheimer's Assoc"},{"issue":"2","key":"4557_CR12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3233\/JAD-210107","volume":"83","author":"K Dhana","year":"2021","unstructured":"Dhana K, James BD, Agarwal P, Aggarwal NT, Cherian LJ, Leurgans SE, Barnes LL, Bennett DA et al (2021) MIND diet, common brain pathologies, and cognition in community-dwelling older adults. J Alzheimer\u2019s Dis JAD 83(2):683\u2013692. https:\/\/doi.org\/10.3233\/JAD-210107","journal-title":"J Alzheimer's Dis JAD"},{"issue":"8","key":"4557_CR13","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.1002\/alz.12982","volume":"19","author":"M Wagner","year":"2023","unstructured":"Wagner M, Agarwal P, Leurgans SE, Bennett DA, Schneider JA, Capuano AW, Grodstein F (2023) The association of MIND diet with cognitive resilience to neuropathologies. Alzheimer\u2019s Dementia 19(8):3644\u20133653. https:\/\/doi.org\/10.1002\/alz.12982","journal-title":"Alzheimer's Dementia"},{"issue":"2","key":"4557_CR14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3233\/JAD-215600","volume":"88","author":"P Agarwal","year":"2022","unstructured":"Agarwal P, Holland TM, James BD, Cherian LJ, Aggarwal NT, Leurgans SE, Bennett DA, Schneider JA (2022) Pelargonidin and Berry Intake Association with Alzheimer\u2019s disease neuropathology: a community-based study. Journal of Alzheimer\u2019s Disease\u202f: JAD 88(2):653\u2013661. https:\/\/doi.org\/10.3233\/JAD-215600","journal-title":"Journal of Alzheimer's Disease : JAD"},{"issue":"3","key":"4557_CR15","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","volume":"79","author":"DJ Newman","year":"2016","unstructured":"Newman DJ, Cragg GM (2016) Natural products as sources of new drugs from 1981 to 2014. J Nat Prod 79(3):629\u2013661. https:\/\/doi.org\/10.1021\/acs.jnatprod.5b01055","journal-title":"J Nat Prod"},{"key":"4557_CR16","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1017\/jns.2016.41","volume":"5","author":"AN Panche","year":"2016","unstructured":"Panche AN, Diwan AD, Chandra SR (2016) Flavonoids: an overview. J Nutr Sci 5:e47. https:\/\/doi.org\/10.1017\/jns.2016.41","journal-title":"J Nutr Sci"},{"issue":"10","key":"4557_CR17","doi-asserted-by":"publisher","first-page":"e1064","DOI":"10.1212\/WNL.0000000000013275","volume":"98","author":"X Zhang","year":"2022","unstructured":"Zhang X, Molsberry SA, Yeh T-S, Cassidy A, Schwarzschild MA, Ascherio A, Gao X (2022) Intake of flavonoids and flavonoid-rich foods and mortality risk among individuals with Parkinson disease: a prospective cohort study. Neurology 98(10):e1064\u2013e1076. https:\/\/doi.org\/10.1212\/WNL.0000000000013275","journal-title":"Neurology"},{"issue":"10","key":"4557_CR18","doi-asserted-by":"publisher","first-page":"e1041","DOI":"10.1212\/WNL.0000000000012454","volume":"97","author":"TS Yeh","year":"2021","unstructured":"Yeh TS, Yuan C, Ascherio A, Rosner BA, Willett WC, Blacker D (2021) Long-term dietary flavonoid intake and subjective cognitive decline in US men and women. Neurology 97(10):e1041\u2013e1056. https:\/\/doi.org\/10.1212\/WNL.0000000000012454","journal-title":"Neurology"},{"issue":"3","key":"4557_CR19","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1073\/pnas.1718683115","volume":"115","author":"C Chen","year":"2018","unstructured":"Chen C, Wang Z, Zhang Z, Liu X, Kang SS, Zhang Y, Ye K (2018) The prodrug of 7,8-dihydroxyflavone development and therapeutic efficacy for treating Alzheimer\u2019s disease. Proc Natl Acad Sci USA 115(3):578\u2013583. https:\/\/doi.org\/10.1073\/pnas.1718683115","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"4557_CR20","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/npp.2013.243","volume":"39","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Liu X, Schroeder JP, Chan C-B, Song M, Yu SP, Weinshenker D, Ye K (2014) 7,8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer\u2019s disease. Neuropsychopharmacology 39(3):638\u2013650. https:\/\/doi.org\/10.1038\/npp.2013.243","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"4557_CR21","doi-asserted-by":"publisher","first-page":"C151","DOI":"10.1152\/ajpcell.00120.2020","volume":"319","author":"C Corr\u00f2","year":"2020","unstructured":"Corr\u00f2 C, Novellasdemunt L, Li VSW (2020) A brief history of organoids. Am J Physiol Cell Physiol 319(1):C151\u2013C165. https:\/\/doi.org\/10.1152\/ajpcell.00120.2020","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"4557_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41392-022-01006-x","volume":"7","author":"S Huang","year":"2022","unstructured":"Huang S, Zhang Z, Cao J, Yu Y, Pei G (2022) Chimeric cerebral organoids reveal the essentials of neuronal and astrocytic APOE4 for Alzheimer\u2019s tau pathology. Signal Transduct Target Ther 7(1):176. https:\/\/doi.org\/10.1038\/s41392-022-01006-x","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"4557_CR23","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nprot.2006.116","volume":"1","author":"CV Vorhees","year":"2006","unstructured":"Vorhees CV, Williams MT (2006) Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 1(2):848\u2013858","journal-title":"Nat Protoc"},{"issue":"1","key":"4557_CR24","doi-asserted-by":"publisher","first-page":"481","DOI":"10.18632\/aging.102637","volume":"12","author":"T Hu","year":"2020","unstructured":"Hu T, Zhou Y, Lu J, Xia P, Chen Y, Cao X, Pei G (2020) A novel rhamnoside derivative PL402 up-regulates matrix metalloproteinase 3\/9 to promote A\u03b2 degradation and alleviates Alzheimer\u2019s-like pathology. Aging (Albany NY) 12(1):481\u2013501. https:\/\/doi.org\/10.18632\/aging.102637","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"4557_CR25","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/nprot.2006.205","volume":"1","author":"RA Bevins","year":"2006","unstructured":"Bevins RA, Besheer J (2006) Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study \u2018recognition memory.\u2019 Nat Protoc 1(3):1306\u20131311","journal-title":"Nat Protoc"},{"key":"4557_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3389\/fnagi.2018.00169","volume":"10","author":"W Yang","year":"2018","unstructured":"Yang W, Zhou K, Zhou Y, An Y, Hu T, Lu J, Huang S, Pei G (2018) Naringin dihydrochalcone ameliorates cognitive deficits and neuropathology in APP\/PS1 transgenic mice. Front Aging Neurosci 10:169. https:\/\/doi.org\/10.3389\/fnagi.2018.00169","journal-title":"Front Aging Neurosci"},{"issue":"6663","key":"4557_CR27","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1126\/science.abp9556","volume":"381","author":"S Balusu","year":"2023","unstructured":"Balusu S, Horr\u00e9 K, Thrupp N, Craessaerts K, Snellinx A, Serneels L, T\u2019Syen D, Chrysidou I et al (2023) MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer\u2019s disease. Science (New York, NY) 381(6663):1176\u20131182. https:\/\/doi.org\/10.1126\/science.abp9556","journal-title":"Science (New York, NY)"},{"issue":"10","key":"4557_CR28","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1038\/nprot.2012.116","volume":"7","author":"Y Shi","year":"2012","unstructured":"Shi Y, Kirwan P, Livesey FJ (2012) Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks. Nat Protoc 7(10):1836\u20131846. https:\/\/doi.org\/10.1038\/nprot.2012.116","journal-title":"Nat Protoc"},{"issue":"5","key":"4557_CR29","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.cell.2005.01.015","volume":"120","author":"O Lazarov","year":"2005","unstructured":"Lazarov O, Robinson J, Tang Y-P, Hairston IS, Korade-Mirnics Z, Lee VMY, Hersh LB, Sapolsky RM et al (2005) Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 120(5):701\u2013713","journal-title":"Cell"},{"key":"4557_CR30","doi-asserted-by":"publisher","unstructured":"Neumann U, Ufer M, Jacobson LH, Rouzade-Dominguez M-L, Huledal G, Kolly C, L\u00fc\u00f6nd RM, Machauer R et al (2018) The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer\u2019s disease. EMBO Mol Med 10(11). https:\/\/doi.org\/10.15252\/emmm.201809316","DOI":"10.15252\/emmm.201809316"},{"issue":"46","key":"4557_CR31","doi-asserted-by":"publisher","first-page":"45937","DOI":"10.1074\/jbc.M306268200","volume":"278","author":"R Bhat","year":"2003","unstructured":"Bhat R, Xue Y, Berg S, Hellberg S, Orm\u00f6 M, Nilsson Y, Rades\u00e4ter A-C, Jerning E et al (2003) Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418. J Biol Chem 278(46):45937\u201345945","journal-title":"J Biol Chem"},{"key":"4557_CR32","unstructured":"Aishwarya V, Sumathi TJIJPP (2015) Chrysin, a natural flavonoid attenuates cognitive dysfunction and neuronal loss associated with amyloid \u03b2 (25\u201335)-induced oxidative stress: an experimental model of Alzheimer\u2019s disease. 7:224\u2013236"},{"key":"4557_CR33","doi-asserted-by":"crossref","unstructured":"Ramalho \u00cdMdM, Bezerra GS, Ostrosky EA, Ferrari M, Oliveira VdS, Wanderley Neto AdO, Quintans JdSS, Passos FRS et al (2022) Chrysin-loaded microemulsion: formulation design, evaluation and antihyperalgesic activity in mice. 12(1):477","DOI":"10.3390\/app12010477"},{"issue":"5","key":"4557_CR34","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3892\/ijmm_00000177","volume":"23","author":"EJ Choi","year":"2009","unstructured":"Choi EJ, Kim G-H (2009) Hepatoprotective effects of daidzein against 7,12-dimetylbenz[a]anthracene-induced oxidative stress in mice. Int J Mol Med 23(5):659\u2013664","journal-title":"Int J Mol Med"},{"key":"4557_CR35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ebiom.2016.03.035","volume":"6","author":"U Sengupta","year":"2016","unstructured":"Sengupta U, Nilson AN, Kayed R (2016) The role of amyloid-\u03b2 oligomers in toxicity, propagation, and immunotherapy. EBioMedicine 6:42\u201349. https:\/\/doi.org\/10.1016\/j.ebiom.2016.03.035","journal-title":"EBioMedicine"},{"issue":"49","key":"4557_CR36","doi-asserted-by":"publisher","first-page":"e2210766119","DOI":"10.1073\/pnas.2210766119","volume":"119","author":"M Habashi","year":"2022","unstructured":"Habashi M, Vutla S, Tripathi K, Senapati S, Chauhan PS, Haviv-Chesner A, Richman M, Mohand S-A et al (2022) Early diagnosis and treatment of Alzheimer\u2019s disease by targeting toxic soluble A\u03b2 oligomers. Proc Natl Acad Sci USA 119(49):e2210766119. https:\/\/doi.org\/10.1073\/pnas.2210766119","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"4557_CR37","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","volume":"11","author":"JM Tarasoff-Conway","year":"2015","unstructured":"Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, Axel L, Rusinek H et al (2015) Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol 11(8):457\u2013470. https:\/\/doi.org\/10.1038\/nrneurol.2015.119","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"4557_CR38","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/aps.2017.28","volume":"38","author":"G-F Chen","year":"2017","unstructured":"Chen G-F, Xu T-H, Yan Y, Zhou Y-R, Jiang Y, Melcher K, Xu HE (2017) Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol Sin 38(9):1205\u20131235. https:\/\/doi.org\/10.1038\/aps.2017.28","journal-title":"Acta Pharmacol Sin"},{"issue":"18","key":"4557_CR39","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1111\/bph.14593","volume":"176","author":"NN Nalivaeva","year":"2019","unstructured":"Nalivaeva NN, Turner AJ (2019) Targeting amyloid clearance in Alzheimer\u2019s disease as a therapeutic strategy. Br J Pharmacol 176(18):3447\u20133463. https:\/\/doi.org\/10.1111\/bph.14593","journal-title":"Br J Pharmacol"},{"issue":"6","key":"4557_CR40","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","volume":"27","author":"O Hansson","year":"2021","unstructured":"Hansson O (2021) Biomarkers for neurodegenerative diseases. Nat Med 27(6):954\u2013963. https:\/\/doi.org\/10.1038\/s41591-021-01382-x","journal-title":"Nat Med"},{"key":"4557_CR41","doi-asserted-by":"publisher","unstructured":"Holper S, Watson R, Yassi N (2022) Tau as a biomarker of neurodegeneration. International Journal of Molecular Sciences 23(13). https:\/\/doi.org\/10.3390\/ijms23137307","DOI":"10.3390\/ijms23137307"},{"issue":"5","key":"4557_CR42","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1586\/ern.10.40","volume":"10","author":"J Avila","year":"2010","unstructured":"Avila J, Wandosell F, Hern\u00e1ndez F (2010) Role of glycogen synthase kinase-3 in Alzheimer\u2019s disease pathogenesis and glycogen synthase kinase-3 inhibitors. Expert Rev Neurother 10(5):703\u2013710. https:\/\/doi.org\/10.1586\/ern.10.40","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"4557_CR43","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S0014-5793(98)01090-4","volume":"436","author":"JZ Wang","year":"1998","unstructured":"Wang JZ, Wu Q, Smith A, Grundke-Iqbal I, Iqbal K (1998) Tau is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase. FEBS Lett 436(1):28\u201334","journal-title":"FEBS Lett"},{"issue":"10","key":"4557_CR44","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1021\/bi051634r","volume":"45","author":"T Li","year":"2006","unstructured":"Li T, Paudel HK (2006) Glycogen synthase kinase 3beta phosphorylates Alzheimer\u2019s disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism. Biochemistry 45(10):3125\u20133133","journal-title":"Biochemistry"},{"key":"4557_CR45","doi-asserted-by":"publisher","unstructured":"Jia X, Jia M, Yang Y, Wang D, Zhou F, Zhang W, Huang X, Guo W et al (2019) Synthesis of novel baicalein amino acid derivatives and biological evaluation as neuroprotective agents. Molecules (Basel, Switzerland) 24(20). https:\/\/doi.org\/10.3390\/molecules24203647","DOI":"10.3390\/molecules24203647"},{"key":"4557_CR46","doi-asserted-by":"publisher","unstructured":"Stompor-Gor\u0105cy M, Bajek-Bil A, Machaczka M (2021) Chrysin: perspectives on contemporary status and future possibilities as pro-health agent. Nutrients 13(6). https:\/\/doi.org\/10.3390\/nu13062038","DOI":"10.3390\/nu13062038"},{"issue":"13","key":"4557_CR47","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1021\/acschemneuro.2c00240","volume":"13","author":"S Saleem","year":"2022","unstructured":"Saleem S, Banerjee R, Rajesh Kannan R (2022) Chrysin-loaded chitosan nanoparticle-mediated neuroprotection in A\u03b21-42-induced neurodegenerative conditions in zebrafish. ACS Chem Neurosci 13(13):2017\u20132034. https:\/\/doi.org\/10.1021\/acschemneuro.2c00240","journal-title":"ACS Chem Neurosci"},{"issue":"6","key":"4557_CR48","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1001\/jamapsychiatry.2023.0800","volume":"80","author":"H Chen","year":"2023","unstructured":"Chen H, Dhana K, Huang Y, Huang L, Tao Y, Liu X, Melo van Lent D, Zheng Y et al (2023) Association of the Mediterranean dietary approaches to stop hypertension intervention for neurodegenerative delay (MIND) diet with the risk of dementia. JAMA Psychiat 80(6):630\u2013638. https:\/\/doi.org\/10.1001\/jamapsychiatry.2023.0800","journal-title":"JAMA Psychiat"},{"key":"4557_CR49","doi-asserted-by":"publisher","unstructured":"Stefaniak O, Dobrzy\u0144ska M, Drzyma\u0142a-Czy\u017c S, Przys\u0142awski J (2022) Diet in the prevention of Alzheimer\u2019s disease: current knowledge and future research requirements. Nutrients 14(21). https:\/\/doi.org\/10.3390\/nu14214564","DOI":"10.3390\/nu14214564"},{"issue":"16","key":"4557_CR50","doi-asserted-by":"publisher","first-page":"e1749","DOI":"10.1212\/WNL.0000000000008981","volume":"94","author":"TM Holland","year":"2020","unstructured":"Holland TM, Agarwal P, Wang Y, Leurgans SE, Bennett DA, Booth SL, Morris MC (2020) Dietary flavonols and risk of Alzheimer dementia. Neurology 94(16):e1749\u2013e1756. https:\/\/doi.org\/10.1212\/WNL.0000000000008981","journal-title":"Neurology"},{"issue":"3","key":"4557_CR51","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3945\/ajcn.115.114553","volume":"103","author":"DJ Lamport","year":"2016","unstructured":"Lamport DJ, Lawton CL, Merat N, Jamson H, Myrissa K, Hofman D, Chadwick HK, Quadt F et al (2016) Concord grape juice, cognitive function, and driving performance: a 12-wk, placebo-controlled, randomized crossover trial in mothers of preteen children. Am J Clin Nutr 103(3):775\u2013783. https:\/\/doi.org\/10.3945\/ajcn.115.114553","journal-title":"Am J Clin Nutr"},{"key":"4557_CR52","doi-asserted-by":"publisher","unstructured":"Mishra A, Mishra PS, Bandopadhyay R, Khurana N, Angelopoulou E, Paudel YN, Piperi C (2021) Neuroprotective potential of chrysin: mechanistic insights and therapeutic potential for neurological disorders. Molecules (Basel, Switzerland) 26(21). https:\/\/doi.org\/10.3390\/molecules26216456","DOI":"10.3390\/molecules26216456"},{"key":"4557_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4137\/PMC.S13210","volume":"7","author":"H Zheng","year":"2015","unstructured":"Zheng H, Fridkin M, Youdim M (2015) New approaches to treating Alzheimer\u2019s disease. Perspect Medicin Chem 7:1\u20138. https:\/\/doi.org\/10.4137\/PMC.S13210","journal-title":"Perspect Medicin Chem"},{"key":"4557_CR54","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.ijbiomac.2019.09.177","volume":"144","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Duan Y, Huang S, Zhou X, Zhou L, Hu T, Yang Y, Lu J et al (2020) Polysaccharides from Lycium barbarum ameliorate amyloid pathology and cognitive functions in APP\/PS1 transgenic mice. Int J Biol Macromol 144:1004\u20131012. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.09.177","journal-title":"Int J Biol Macromol"},{"key":"4557_CR55","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3389\/fimmu.2020.00162","volume":"11","author":"Y An","year":"2020","unstructured":"An Y, Zhang H, Huang S, Pei G (2020) PL201, a reported rhamnoside against Alzheimer\u2019s disease pathology, alleviates neuroinflammation and stimulates Nrf2 signaling. Front Immunol 11:162. https:\/\/doi.org\/10.3389\/fimmu.2020.00162","journal-title":"Front Immunol"},{"issue":"1","key":"4557_CR56","doi-asserted-by":"publisher","first-page":"199","DOI":"10.7150\/ijms.51382","volume":"18","author":"AA Alkahtane","year":"2021","unstructured":"Alkahtane AA, Alghamdi HA, Almutairi B, Khan MM, Hasnain MS, Abdel-Daim MM, Alghamdi WM, Alkahtani S (2021) Inhibition of human amylin aggregation by flavonoid chrysin: an in-silico and in-vitro approach. Int J Med Sci 18(1):199\u2013206. https:\/\/doi.org\/10.7150\/ijms.51382","journal-title":"Int J Med Sci"},{"key":"4557_CR57","doi-asserted-by":"publisher","first-page":"105976","DOI":"10.1016\/j.ejps.2021.105976","volume":"166","author":"C Liu","year":"2021","unstructured":"Liu C, Kou X, Wang X, Wu J, Yang A, Shen R (2021) Novel chrysin derivatives as hidden multifunctional agents for anti-Alzheimer\u2019s disease: design, synthesis and in vitro evaluation. Eur J Pharm Sci 166:105976. https:\/\/doi.org\/10.1016\/j.ejps.2021.105976","journal-title":"Eur J Pharm Sci"},{"key":"4557_CR58","doi-asserted-by":"publisher","first-page":"109118","DOI":"10.1016\/j.intimp.2022.109118","volume":"111","author":"Q Wang","year":"2022","unstructured":"Wang Q, Yang Z, Wu X, Zhang X, Geng F, Wang Q, Geng Z, Yu C et al (2022) Chrysin alleviates lipopolysaccharide-induced neuron damage and behavioral deficits in mice through inhibition of Fyn. Int Immunopharmacol 111:109118. https:\/\/doi.org\/10.1016\/j.intimp.2022.109118","journal-title":"Int Immunopharmacol"},{"key":"4557_CR59","doi-asserted-by":"publisher","first-page":"112696","DOI":"10.1016\/j.bbr.2020.112696","volume":"390","author":"R Giacomeli","year":"2020","unstructured":"Giacomeli R, de Gomes MG, Reolon JB, Haas SE, Colom\u00e9 LM, Jesse CR (2020) Chrysin loaded lipid-core nanocapsules ameliorates neurobehavioral alterations induced by \u03b2-amyloid1-42 in aged female mice. Behav Brain Res 390:112696. https:\/\/doi.org\/10.1016\/j.bbr.2020.112696","journal-title":"Behav Brain Res"},{"issue":"1","key":"4557_CR60","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","volume":"20","author":"Y Chen","year":"2023","unstructured":"Chen Y, Yu Y (2023) Tau and neuroinflammation in Alzheimer\u2019s disease: interplay mechanisms and clinical translation. J Neuroinflammation 20(1):165. https:\/\/doi.org\/10.1186\/s12974-023-02853-3","journal-title":"J Neuroinflammation"},{"issue":"1","key":"4557_CR61","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12974-020-01820-6","volume":"17","author":"R Ismail","year":"2020","unstructured":"Ismail R, Parbo P, Madsen LS, Hansen AK, Hansen KV, Schaldemose JL, Kjeldsen PL, Stokholm MG et al (2020) The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer\u2019s disease: a longitudinal PET study. J Neuroinflammation 17(1):151. https:\/\/doi.org\/10.1186\/s12974-020-01820-6","journal-title":"J Neuroinflammation"},{"issue":"5","key":"4557_CR62","doi-asserted-by":"publisher","first-page":"734","DOI":"10.31857\/S0026898421050049","volume":"55","author":"DG Garbuz","year":"2021","unstructured":"Garbuz DG, Zatsepina OG, Evgen\u2019ev MB (2021) Beta amyloid, tau protein, and neuroinflammation: an attempt to integrate different hypotheses of Alzheimer\u2019s disease pathogenesis. Mol Biol (Mosk) 55(5):734\u2013747. https:\/\/doi.org\/10.31857\/S0026898421050049","journal-title":"Mol Biol (Mosk)"},{"key":"4557_CR63","doi-asserted-by":"publisher","first-page":"101133","DOI":"10.1016\/j.redox.2019.101133","volume":"22","author":"S Chen","year":"2019","unstructured":"Chen S, Chen S-T, Sun Y, Xu Z, Wang Y, Yao S-Y, Yao W-B, Gao X-D (2019) Fibroblast growth factor 21 ameliorates neurodegeneration in rat and cellular models of Alzheimer\u2019s disease. Redox Biol 22:101133. https:\/\/doi.org\/10.1016\/j.redox.2019.101133","journal-title":"Redox Biol"},{"issue":"2","key":"4557_CR64","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.neurobiolaging.2014.10.004","volume":"36","author":"L Katsouri","year":"2015","unstructured":"Katsouri L, Ashraf A, Birch AM, Lee KKL, Mirzaei N, Sastre M (2015) Systemic administration of fibroblast growth factor-2 (FGF2) reduces BACE1 expression and amyloid pathology in APP23 mice. Neurobiol Aging 36(2):821\u2013831. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.10.004","journal-title":"Neurobiol Aging"},{"key":"4557_CR65","doi-asserted-by":"publisher","first-page":"112080","DOI":"10.1016\/j.biopha.2021.112080","volume":"142","author":"S Gao","year":"2021","unstructured":"Gao S, Siddiqui N, Etim I, Du T, Zhang Y, Liang D (2021) Developing nutritional component chrysin as a therapeutic agent: bioavailability and pharmacokinetics consideration, and ADME mechanisms. Biomed Pharmacother 142:112080. https:\/\/doi.org\/10.1016\/j.biopha.2021.112080","journal-title":"Biomed Pharmacother"},{"key":"4557_CR66","doi-asserted-by":"crossref","unstructured":"Seo D-o, Holtzman DMJE, medicine m (2024) Current understanding of the Alzheimer\u2019s disease-associated microbiome and therapeutic strategies. 56 (1):86\u201394","DOI":"10.1038\/s12276-023-01146-2"},{"key":"4557_CR67","doi-asserted-by":"crossref","unstructured":"Giacomeli R, de Gomes MG, Reolon JB, Haas SE, Colom\u00e9 LM, Jesse CRJBBR (2020) Chrysin loaded lipid-core nanocapsules ameliorates neurobehavioral alterations induced by \u03b2-amyloid1\u201342 in aged female mice. 390:112696","DOI":"10.1016\/j.bbr.2020.112696"},{"key":"4557_CR68","doi-asserted-by":"crossref","unstructured":"Xu D, Jin J, Yu H, Zhao Z, Ma D, Zhang C, Jiang HJJoE, Research CC (2017) Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2. 36:1\u201311","DOI":"10.1186\/s13046-017-0514-4"},{"issue":"1","key":"4557_CR69","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.apsb.2020.07.011","volume":"11","author":"J Chen","year":"2021","unstructured":"Chen J, Wang Y, Zhao D, Zhang L, Zhang W, Fan J, Li J, Zhan Q (2021) Chrysin serves as a novel inhibitor of DGK\u03b1\/FAK interaction to suppress the malignancy of esophageal squamous cell carcinoma (ESCC). Acta Pharm Sin B 11(1):143\u2013155. https:\/\/doi.org\/10.1016\/j.apsb.2020.07.011","journal-title":"Acta Pharm Sin B"},{"key":"4557_CR70","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.bbi.2019.02.005","volume":"79","author":"Z Li","year":"2019","unstructured":"Li Z, Chu S, He W, Zhang Z, Liu J, Cui L, Yan X, Li D et al (2019) A20 as a novel target for the anti-neuroinflammatory effect of chrysin via inhibition of NF-\u03baB signaling pathway. Brain Behav Immun 79:228\u2013235. https:\/\/doi.org\/10.1016\/j.bbi.2019.02.005","journal-title":"Brain Behav Immun"},{"issue":"3","key":"4557_CR71","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s12015-020-10069-8","volume":"17","author":"C Hadjichristou","year":"2021","unstructured":"Hadjichristou C, About I, Koidis P, Bakopoulou A (2021) Advanced in vitro experimental models for tissue engineering-based reconstruction of a 3D dentin\/pulp complex: a literature review. Stem Cell Rev Rep 17(3):785\u2013802. https:\/\/doi.org\/10.1007\/s12015-020-10069-8","journal-title":"Stem Cell Rev Rep"},{"issue":"11","key":"4557_CR72","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/s41592-019-0586-5","volume":"16","author":"B Cakir","year":"2019","unstructured":"Cakir B, Xiang Y, Tanaka Y, Kural MH, Parent M, Kang Y-J, Chapeton K, Patterson B et al (2019) Engineering of human brain organoids with a functional vascular-like system. Nat Methods 16(11):1169\u20131175. https:\/\/doi.org\/10.1038\/s41592-019-0586-5","journal-title":"Nat Methods"},{"issue":"7986","key":"4557_CR73","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41586-023-06713-1","volume":"623","author":"DS Park","year":"2023","unstructured":"Park DS, Kozaki T, Tiwari SK, Moreira M, Khalilnezhad A, Torta F, Olivi\u00e9 N, Thiam CH et al (2023) iPS-cell-derived microglia promote brain organoid maturation via cholesterol transfer. Nature 623(7986):397\u2013405. https:\/\/doi.org\/10.1038\/s41586-023-06713-1","journal-title":"Nature"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04557-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04557-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04557-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:07:23Z","timestamp":1741082843000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04557-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["4557"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04557-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,21]]},"assertion":[{"value":"24 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments in this study were conducted according to the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Animal experiments were performed under protocols approved by the Institutional Animal Care and Utilization Committee (SIBCB-S309-2204\u201306).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}